Phone
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
Clinic Signification:
1.The BCR/ABL fusion gene is a marker of CML and is also present in 30% of adult ALL, about 10% of child ALL, and a small amount of AML. In ALL, it means that the prognosis is extremely poor.
2.Guiding medication, used to guide the use of targeted therapy Gleevec, treatment options and drug efficacy evaluation.
ABL/BCR Negative
ABL/BCR Positive
Probe Description: ABL/BCR
Cat.No.: CF1240
Specification: 10 tests/box, 20 tests/box